HPLC-MS/MS-Mediated Analysis of the Pharmacokinetics, Bioavailability, and Tissue Distribution of Schisandrol B in Rats

Figure 2

Typical chromatograms of Schisandrol B and IS in blank rat plasma (a) and liver homogenates (b); blank rat plasma (c) and liver homogenates (d) spiked with LLOQ and IS; and rat plasma (e) at 1 h and liver homogenate samples at 0.5 h (f) following the oral administration of 10 mg/kg Schisandrol B. A corresponds to Schisandrol B, and B corresponds to IS.

(a)

(b)

(c)

(d)

(e)

(f)